The genetics of the corneal dystrophies

Corneal Dystrophies

Volumn 48, Issue , 2011, Pages 51-66

  Aldave, Anthony J ^a  

^a JULES STEIN EYE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; SCLEROPROTEIN; TRANSFORMING GROWTH FACTOR BETA;

BIOSYNTHESIS; CONGENITAL CORNEA DYSTROPHY; CORNEA; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION; GENETICS; HUMAN; METABOLISM; MUTATION; PATHOLOGY; REVIEW;

CORNEA; CORNEAL DYSTROPHIES, HEREDITARY; DNA; EXTRACELLULAR MATRIX PROTEINS; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MUTATION; TRANSFORMING GROWTH FACTOR BETA;

EID: 84926114756     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1159/000324077     Document Type: Chapter

References (91)

1. Aldave AJ, Sonmez B: Elucidating the molecular genetic basis of the corneal dystrophies: are we there yet? Arch Ophthalmol 2007;125:177-186.
2. Weiss JS, Moller HU, Lisch W, et al: The IC3D classification of the corneal dystrophies. Cornea 2008; 27(suppl 2):S1-S83.
3. Hilton EN, Black GC, Manson FD, et al: De novo mutation in the BIGH3/TGFB1 gene causing granular corneal dystrophy. Br J Ophthalmol 2007;91:1083-1084.
4. Zhao XC, Nakamura H, Subramanyam S, et al:Spontaneous and inheritable R555Q mutation in the TGFBI/BIGH3 gene in two unrelated families exhibiting Bowman's layer corneal dystrophy. Ophthalmology 2007;114:e39-e46.
5. Tanhehco TY, Eifrig DE Jr, Schwab IR, et al: Two cases of Reis-Bucklers corneal dystrophy (granular corneal dystrophy type III) caused by spontaneous mutations in the TGFBI gene. Arch Ophthalmol 2006;124:589-593.
6. Yellore VS, Sonmez B, Chen MC, et al: An unusual presentation of macular corneal dystrophy associated with uniparental isodisomy and a novel Leu173Pro mutation. Ophthalmic Genet 2007;28:169-174.
7. Irvine AD, Corden LD, Swensson O, et al: Mutations in cornea-specific keratin K3 or K12 genes cause Meesmann's corneal dystrophy. Nat Genet 1997;16:184-187.
8. Aldave AJ, Yellore VS, Vo RC, et al: Exclusion of positional candidate gene coding region mutations in the common posterior polymorphous corneal dystrophy 1 candidate gene interval. Cornea 2009; 28:801-807.
9. Aldave AJ, Yellore VS, Yu F, et al: Posterior polymorphous corneal dystrophy is associated with TCF8 gene mutations and abdominal hernia. Am J Med Genet A 2007;143A:2549-2556.
10. Heon E, Mathers WD, Alward WL, et al: Linkage of posterior polymorphous corneal dystrophy to 20q11. Hum Mol Genet 1995;4:485-488.
11. Krafchak CM, Pawar H, Moroi SE, et al: Mutations in TCF8 cause posterior polymorphous corneal dystrophy and ectopic expression of COL4A3 by corneal endothelial cells. Am J Hum Genet 2005; 77:694-708.
12. Liskova P, Tuft SJ, Gwilliam R, et al: Novel mutations in the ZEB1 gene identified in Czech and British patients with posterior polymorphous corneal dystrophy. Hum Mutat 2007;28:638.
13. Nguyen DQ, Hosseini M, Billingsley G, et al: Clinical phenotype of posterior polymorphous corneal dystrophy in a family with a novel ZEB1 mutation. Acta Ophthalmol 2010;88:695-699.
14. Biswas S, Munier FL, Yardley J, et al: Missense mutations in COL8A2, the gene encoding the alpha2 chain of type VIII collagen, cause two forms of corneal endothelial dystrophy. Hum Mol Genet 2001; 10:2415-2423.
15. Kobayashi A, Fujiki K, Murakami A, et al: Analysis of COL8A2 gene mutation in Japanese patients with Fuchs' endothelial dystrophy and posterior polymorphous dystrophy. Jpn J Ophthalmol 2004;48:195-198.
16. Yellore VS, Rayner SA, Emmert-Buck L, et al: No pathogenic mutations identified in the COL8A2 gene or four positional candidate genes in patients with posterior polymorphous corneal dystrophy. Invest Ophthalmol Vis Sci 2005;46:1599-603.
17. El Kochairi I, Letovanec I, Uffer S, et al: Systemic investigation of keratoepithelin deposits in TGFBI/ BIGH3-related corneal dystrophy. Mol Vis 2006;12:461-466.
18. Lee JH, Chung SH, Stulting RD, et al: Effects of corneal neovascularization on the manifestations of Avellino corneal dystrophy (granular corneal dystrophy type II). Cornea 2006;25:914-918.
19. Klintworth GK, Oshima E, al-Rajhi A, et al: Macular corneal dystrophy in Saudi Arabia: a study of 56 cases and recognition of a new immunophenotype. Am J Ophthalmol 1997;124:9-18.
20. Bron AJ, Williams HP, Carruthers ME: Hereditary crystalline stromal dystrophy of Schnyder. 1. Clinical features of a family with hyperlipoproteinaemia. Br J Ophthalmol 1972;56:383-399.
21. Battisti C, Dotti MT, Malandrini A, et al: Schnyder corneal crystalline dystrophy: description of a new family with evidence of abnormal lipid storage in skin fibroblasts. Am J Med Genet 1998;75:35-39.
22. Aldave AJ, Rayner SA, King JA, et al: A unique corneal dystrophy of Bowman's layer and stroma associated with the Gly623Asp mutation in the transforming growth factor beta-induced (TGFBI) gene. Ophthalmology 2005;112:1017-1022.
23. Anderson NJ, Badawi DY, Grossniklaus HE, Stulting RD: Posterior polymorphous membranous dystrophy with overlapping features of iridocorneal endothelial syndrome. Arch Ophthalmol 2001;119:624-625.
24. Stewart H, Black GC, Donnai D, et al: A mutation within exon 14 of the TGFBI (BIGH3) gene on chromosome 5q31 causes an asymmetric, late-onset form of lattice corneal dystrophy. Ophthalmology 1999;106:964-970.
25. Nakagawa Asahina S, Fujiki K, Enomoto Y, et al: Case of late onset and isolated lattice corneal dystrophy with Asn544Ser (N544S) mutation of transforming growth factor beta-induced (TGFBI, BIGH3) gene. Nippon Ganka Gakkai Zasshi 2004;108:618-620.
26. Hirano K, Hotta Y, Nakamura M, et al: Late-onset form of lattice corneal dystrophy caused by leu527Arg mutation of the TGFBI gene. Cornea 2001;20:525-529.
27. Aldave AJ, Rayner SA, Kim BT, et al: Unilateral lattice corneal dystrophy associated with the novel His572del mutation in the TGFBI gene. Mol Vis 2006;12:142-146.
28. Aldave AJ: The clinical utility of genetic analysis in the diagnosis and management of inherited corneal disorders. Contemp Ophthalmol 2005;4:1-10.
29. Akhtar S, Meek KM, Ridgway AE, et al: Deposits and proteoglycan changes in primary and recurrent granular dystrophy of the cornea. Arch Ophthalmol 1999;117:310-321.
30. Johnson BL, Brown SI, Zaidman GW: A light and electron microscopic study of recurrent granular dystrophy of the cornea. Am J Ophthalmol 1981;92:49-58.
31. Stone EM, Mathers WD, Rosenwasser GO, et al: Three autosomal dominant corneal dystrophies map to chromosome 5q. Nat Genet 1994;6:47-51.
32. Munier FL, Korvatska E, Djemai A, et al: Keratoepithelin mutations in four 5q31-linked corneal dystrophies. Nat Genet 1997;15:247-251.
33. Jiao X, Sultana A, Garg P, et al: Autosomal recessive corneal endothelial dystrophy (CHED2) is associated with mutations in SLC4A11. J Med Genet 2007; 44:64-68.
34. Sultana A, Garg P, Ramamurthy B, et al: Mutational spectrum of the SLC4A11 gene in autosomal recessive congenital hereditary endothelial dystrophy. Mol Vis 2007;13:1327-1332.
35. Kumar A, Bhattacharjee S, Prakash DR, Sadanand CS: Genetic analysis of two Indian families affected with congenital hereditary endothelial dystrophy:two novel mutations in SLC4A11. Mol Vis 2007;13:39-46.
36. Aldave AJ, Yellore VS, Bourla N, et al: Autosomal recessive CHED associated with novel compound heterozygous mutations in SLC4A11. Cornea 2007; 26:896-900.
37. Ramprasad VL, Ebenezer ND, Aung T, et al: Novel SLC4A11 mutations in patients with recessive congenital hereditary endothelial dystrophy (CHED2). Hum Mut 2007;28:522-523.
38. Vithana EN, Morgan P, Sundaresan P, et al: Mutations in sodium-borate cotransporter SLC4A11 cause recessive congenital hereditary endothelial dystrophy (CHED2). Nat Genet 2006;38:755-757.
39. Hemadevi B, Veitia RA, Srinivasan M, et al: Identification of mutations in the SLC4A11 gene in patients with recessive congenital hereditary endothelial dystrophy. Arch Ophthalmol 2008;126:700-708.
40. Aldahmesh MA, Khan AO, Meyer BF, Alkuraya FS: Mutational spectrum of SLC4A11 in autosomal recessive CHED in Saudi Arabia. Invest Ophthalmol Vis Sci 2009;50:4142-4145.
41. Shah SS, Al-Rajhi A, Brandt JD, et al: Mutation in the SLC4A11 gene associated with autosomal recessive congenital hereditary endothelial dystrophy in a large Saudi family. Ophthalmic Genet 2008;29:41-45.
42. Li S, Tiab L, Jiao X, et al: Mutations in PIP5K3 are associated with François-Neetens mouchetée fleck corneal dystrophy. Am J Hum Genet 2005;77:54-63.
43. Aldave AJ, Rayner SA, Salem AK, et al: No pathogenic mutations identified in the COL8A1 and COL8A2 genes in familial Fuchs corneal dystrophy. Invest Ophthalmol Vis Sci 2006;47:3787-3790.
44. Aldave AJ, Yellore VS, Principe AH, et al: Candidate gene screening for posterior polymorphous dystrophy. Cornea 2005;24:151-155.
45. Gwilliam R, Liskova P, Filipec M, et al: Posterior polymorphous corneal dystrophy in Czech families maps to chromosome 20 and excludes the VSX1 gene. Invest Ophthalmol Vis Sci 2005;46:4480-4484.
46. Yellore VS, Khan MA, Bourla N, et al: Identification of mutations in UBIAD1 following exclusion of coding mutations in the chromosome 1p36 locus for Schnyder crystalline corneal dystrophy. Mol Vis 2007;13:1777-1782.
47. Germain DP: Pseudoxanthoma elasticum: evidence for the existence of a pseudogene highly homologous to the ABCC6 gene. J Med Genet 2001;38:457-461.
48. North KN, Yang N, Wattanasirichaigoon D, et al: A common nonsense mutation results in alphaactinin-3 deficiency in the general population. Nat Genet 1999;21:353-354.
49. Zhang X, Yeung KY, Pang CP, Fu W: Mutation analysis of retinitis pigmentosa 1 gene in Chinese with retinitis pigmentosa. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2002;19:194-197.
50. Heon E, Greenberg A, Kopp KK, et al: VSX1: a gene for posterior polymorphous dystrophy and keratoconus. Hum Mol Genet 2002;11:1029-1036.
51. Mintz-Hittner HA, Semina EV, Frishman LJ, et al: VSX1 (RINX) mutation with craniofacial anomalies, empty sella, corneal endothelial changes, and abnormal retinal and auditory bipolar cells. Ophthalmology 2004;111:828-836.
52. Valleix S, Nedelec B, Rigaudiere F, et al: H244R VSX1 is associated with selective cone ON bipolar cell dysfunction and macular degeneration in a PPCD family. Invest Ophthalmol Vis Sci 2006;47:48-54.
53. Gottsch JD, Sundin OH, Liu SH, et al: Inheritance of a novel COL8A2 mutation defines a distinct earlyonset subtype of fuchs corneal dystrophy. Invest Ophthalmol Vis Sci 2005;46:1934-1939.
54. Liskova P, Prescott Q, Bhattacharya SS, Tuft SJ: British family with early-onset Fuchs' endothelial corneal dystrophy associated with p.L450W mutation in the COL8A2 gene. Br J Ophthalmol 2007;91:1717-1718.
55. Vithana EN, Morgan PE, Ramprasad V, et al: SLC4A11 mutations in Fuchs endothelial corneal dystrophy. Hum Mol Genet 2008;17:656-666.
56. Klintworth GK, Vogel FS: Macular corneal dystrophy. An inherited acid mucopolysaccharide storage disease of the corneal fibroblast. Am J Pathol 1964; 45:565-586.
57. Hassell JR, Newsome DA, Krachmer JH, Rodrigues MM: Macular corneal dystrophy: failure to synthesize a mature keratan sulfate proteoglycan. Proc Natl Acad Sci USA 1980;77:3705-3709.
58. Midura RJ, Hascall VC, MacCallum DK, et al: Proteoglycan biosynthesis by human corneas from patients with types 1 and 2 macular corneal dystrophy. J Biol Chem 1990;265:15947-15955.
59. Akama TO, Nishida K, Nakayama J, et al: Macular corneal dystrophy type I and type II are caused by distinct mutations in a new sulphotransferase gene. Nat Genet 2000;26:237-241.
60. Bonanno JA: Identity and regulation of ion transport mechanisms in the corneal endothelium. Prog Retin Eye Res 2003;22:69-94.
61. Thapa N, Lee BH, Kim IS: TGFBIp/betaig-h3 protein:a versatile matrix molecule induced by TGFbeta. Int J Biochem Cell Biol 2007;39:2183-2194.
62. Lopez IA, Rosenblatt MI, Kim C, et al: Slc4a11 gene disruption in mice: cellular targets of sensorineuronal abnormalities. J Biol Chem 2009;284:26882-26896.
63. Schmitt-Bernard CF, Chavanieu A, Herrada G, et al: BIGH3 (TGFBI) Arg124 mutations influence the amyloid conversion of related peptides in vitro. Eur J Biochem 2002;269:5149-5156.
64. Bainbridge JW, Smith AJ, Barker SS, et al: Effect of gene therapy on visual function in Leber's congenital amaurosis. N Engl J Med 2008;358:2231-2239.
65. Cideciyan AV, Hauswirth WW, Aleman TS, et al:Human RPE65 gene therapy for Leber congenital amaurosis: persistence of early visual improvements and safety at 1 year. Hum Gene Ther 2009;20:999-1004.
66. Mancuso K, Hauswirth WW, Li Q, et al: Gene therapy for red-green colour blindness in adult primates. Nature 2009;461:784-787.
67. Klausner EA, Peer D, Chapman RL, et al: Corneal gene therapy. J Control Release 2007;124:107-133.
68. Mohan RR, Sharma A, Netto MV, et al: Gene therapy in the cornea. Prog Retin Eye Res 2005;24:537-559.
69. Borras T, Gabelt BT, Klintworth GK, et al: Noninvasive observation of repeated adenoviral GFP gene delivery to the anterior segment of the monkey eye in vivo. J Gene Med 2001;3:437-449.
70. Klebe S, Sykes PJ, Coster DJ, et al: Prolongation of sheep corneal allograft survival by ex vivo transfer of the gene encoding interleukin-10. Transplantation 2001;71:1214-1220.
71. Bennett J, Maguire AM: Gene therapy for ocular disease. Mol Ther 2000;1:501-505.
72. Pleyer U, Dannowski H: Delivery of genes via liposomes to corneal endothelial cells. Drug News Perspect 2002;15:283-289.
73. Lyons CJ, McCartney AC, Kirkness CM, et al: Granular corneal dystrophy. Visual results and pattern of recurrence after lamellar or penetrating keratoplasty. Ophthalmology 1994;101:1812-1817.
74. Marcon AS, Cohen EJ, Rapuano CJ, Laibson PR: Recurrence of corneal stromal dystrophies after penetrating keratoplasty. Cornea 2003;22:19-21.
75. Meisler DM, Fine M: Recurrence of the clinical signs of lattice corneal dystrophy (type I) in corneal transplants. Am J Ophthalmol 1984;97:210-214.
76. Sorour HM, Yee SB, Peterson NJ, et al: Recurrence of chromosome 10 Thiel-Behnke corneal dystrophy (CDB2) after excimer laser phototherapeutic keratectomy or penetrating keratoplasty. Cornea 2005; 24:45-50.
77. Dinh R, Rapuano CJ, Cohen EJ, Laibson PR: Recurrence of corneal dystrophy after excimer laser phototherapeutic keratectomy. Ophthalmology 1999;106:1490-1497.
78. Dogru M, Katakami C, Nishida T, Yamanaka A:Alteration of the ocular surface with recurrence of granular/avellino corneal dystrophy after phototherapeutic keratectomy: report of five cases and literature review. Ophthalmology 2001;108:810-817.
79. Ellies P, Bejjani RA, Bourges JL, et al: Phototherapeutic keratectomy for BIGH3-linked corneal dystrophy recurring after penetrating keratoplasty. Ophthalmology 2003;110:1119-1125.
80. Inoue T, Watanabe H, Yamamoto S, et al: Recurrence of corneal dystrophy resulting from an R124H Big-h3 mutation after phototherapeutic keratectomy. Cornea 2002;21:570-573.
81. Orndahl MJ, Fagerholm PP: Treatment of corneal dystrophies with phototherapeutic keratectomy. J Refract Surg 1998;14:129-135.
82. Karring H, Valnickova Z, Thogersen IB, et al: Evidence against a blood derived origin for transforming growth factor beta induced protein in corneal disorders caused by mutations in the TGFBI gene. Mol Vis 2007;13:997-1004.
83. Aldave AJ, Sonmez B, Forstot SL, et al: A clinical and histopathologic examination of accelerated TGFBIp deposition after LASIK in combined granular-lattice corneal dystrophy. Am J Ophthalmol 2007;143:416-419.
84. Banning CS, Kim WC, Randleman JB, et al: Exacerbation of Avellino corneal dystrophy after LASIK in North America. Cornea 2006;25:482-484.
85. Jun RM, Tchah H, Kim TI, et al: Avellino corneal dystrophy after LASIK. Ophthalmology 2004;111:463-468.
86. Kim TI, Kim T, Kim SW, Kim EK: Comparison of corneal deposits after LASIK and PRK in eyes with granular corneal dystrophy type II. J Refract Surg 2008;24:392-395.
87. Kim TI, Roh MI, Grossniklaus HE, et al: Deposits of transforming growth factor-beta-induced protein in granular corneal dystrophy type II after LASIK. Cornea 2008;27:28-32.
88. Wan XH, Lee HC, Stulting RD, et al: Exacerbation of Avellino corneal dystrophy after laser in situ keratomileusis. Cornea 2002;21:223-226.
89. Yellore VS, Rayner SA, Aldave AJ: TGFB1-induced extracellular expression of TGFBIp and inhibition of TGFBIp expression by RNA interference in a human corneal epithelial cell line. Invest Ophthalmol Vis Sci 2011;52:757-763.
90. Yuan C, Zins EJ, Clark AF, Huang AJ: Suppression of keratoepithelin and myocilin by small interfering RNAs (siRNA) in vitro. Mol Vis 2007;13:2083-2095.
91. Zhang Y, Wen G, Shao G, et al: TGFBI deficiency predisposes mice to spontaneous tumor development. Cancer Res 2009;69:37-44.